BCI 2017 Latin America Special Report:
Insights about the impact of biopharmaceutical policies on investment decisions in Latin America.
FIFARMA supports and joins LAPA Latin American Patients Academy:
GAfPA, Alianza Latina & IAPO commitment to advance the education and training of the Patient Advocacy Community in Latin America.
We are FIFARMA, the Latin American Federation of Pharmaceutical Industry, a regional organization created in 1962 which represents 13 Research and Development Pharmaceutical Companies and 9 local Trade Associations across the Latin American region.
We are engaged in the development of policies that foster the access to high quality pharmaceutical innovations that prolong, preserve and improve life for patients in Latin America led by strict ethical principles focused on patients´ safety.